Dorota Szczesna

Dr. Dorota Szczesna

Medical University of Lodz (Poland)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2017 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
MTMarika Turek
Marika Turek
DSDorota Szczesna
Dorota Szczesna
MKMarek Koprowski
Marek Koprowski
Piotr BałczewskiPiotr Bałczewski
Piotr Bałczewski
This comprehensive review describes methods for the preparation of 1-indanones published in original and patent literature from 1926 to 2017. More than 100 synthetic methods utilizing carboxylic acids, esters, diesters, acid chlorides, ketones, alkynes, alcohols etc. as starting materials, have been performed. This review also covers the most important studies on the biological activity of 1-indanones and their derivatives which are potent antiviral, anti-inflammatory, analgesic, antimalarial, antibacterial and anticancer compounds. Moreover, they can be used in the treatment of neurodegenerative diseases and as effective insecticides, fungicides and herbicides.

11 August 2016 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
Małgorzata Bukowiecka-MatusiakMałgorzata Bukowiecka-Matusiak
Małgorzata Bukowiecka-Matusiak
MCMałgorzata Chmielewska-Kassassir
Małgorzata Chmielewska-Kassassir
DSDorota Szczesna
Dorota Szczesna
LWLucyna Wozniak
Lucyna Wozniak
In recent years, metabolomics has become a necessary tool for understanding the impact of external and pathological factors on the operation of biological systems. The first reports of metabolomics date back to the 1970s, however, the area only began to develop dynamically at the beginning of this century and has proved effective only during the present decade. The five primary tools used in this form of analysis are NMR spectrometry, HPLC, TLC-UV, GC-MS and LC-MS/MS, with MS as the most universal approach, particularly when used together with chromatographic separation and NMR. Diabetes mellitus type 2 (T2DM) is a rapidly growing problem with global consequences. The metabolomic approach has been extensively applied to examining T2DM, insulin resistance and obesity, not only to assess the development of the disease, but also to discover its potential biomarkers. The presented review summarizes current studies on lipidomic and proteomic profiles in the context of different types of diabetes mellitus disease (T1DM, T2DM and GDM), as determined by chromatography-coupled mass spectrometry.